Vitrolife AB (publ) (STO:VITR)
Sweden · Delayed Price · Currency is SEK 96.90
-1.10 (-1.12%)
Oct 15, 2026, 3:28 PM CET
Vitrolife AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 13,122 | 18,553 | 29,110 | 26,361 | 25,210 | 75,821 | |
Market Cap Growth | -29.93% | -36.27% | 10.43% | 4.57% | -66.75% | 223.67% |
Enterprise Value | 13,902 | 19,447 | 30,238 | 27,740 | 26,973 | 71,131 |
Last Close Price | 98.00 | 135.60 | 211.25 | 190.09 | 181.12 | 542.98 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 56.74 | - | 63.99 | 222.35 |
Forward PE | 19.68 | 31.52 | 39.23 | 35.66 | 36.02 | 113.91 |
PS Ratio | 3.91 | 5.39 | 8.07 | 7.51 | 7.80 | 45.11 |
PB Ratio | 1.63 | 2.35 | 2.13 | 2.07 | 1.51 | 4.94 |
P/FCF Ratio | 21.65 | 40.33 | 35.72 | 38.21 | 43.10 | 211.20 |
P/OCF Ratio | 18.26 | 29.22 | 32.10 | 34.82 | 39.64 | 197.45 |
PEG Ratio | - | 2.10 | 2.19 | 2.19 | 2.19 | 1.22 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.14 | 5.65 | 8.38 | 7.90 | 8.34 | 42.31 |
EV/EBITDA Ratio | 13.59 | 20.64 | 25.89 | 25.06 | 27.22 | 140.57 |
EV/EBIT Ratio | 22.23 | 33.88 | 38.18 | 37.59 | 41.69 | 165.81 |
EV/FCF Ratio | 22.92 | 42.28 | 37.10 | 40.20 | 46.11 | 198.14 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.20 | 0.20 | 0.15 | 0.16 | 0.13 | 0.16 |
Debt / EBITDA Ratio | 1.55 | 1.62 | 1.72 | 1.83 | 2.18 | 4.74 |
Debt / FCF Ratio | 2.61 | 3.49 | 2.56 | 3.03 | 3.80 | 6.91 |
Net Debt / Equity Ratio | 0.10 | 0.10 | 0.07 | 0.10 | 0.10 | 0.12 |
Net Debt / EBITDA Ratio | 0.79 | 0.85 | 0.82 | 1.11 | 1.66 | 3.66 |
Net Debt / FCF Ratio | 1.27 | 1.73 | 1.17 | 1.78 | 2.82 | 5.16 |
Asset Turnover | 0.24 | 0.24 | 0.21 | 0.19 | 0.16 | 0.16 |
Inventory Turnover | 3.18 | 3.46 | 3.52 | 3.75 | 4.05 | 2.46 |
Quick Ratio | 2.76 | 2.61 | 2.65 | 2.59 | 1.80 | 1.11 |
Current Ratio | 3.64 | 3.40 | 3.34 | 3.44 | 2.53 | 1.48 |
Return on Equity (ROE) | -46.53% | -46.54% | 3.90% | -26.14% | 2.46% | 3.96% |
Return on Assets (ROA) | 2.81% | 2.51% | 2.93% | 2.50% | 2.02% | 2.47% |
Return on Invested Capital (ROIC) | 7.15% | 4.93% | 4.23% | 4.56% | 2.67% | 3.51% |
Return on Capital Employed (ROCE) | 5.90% | 5.50% | 4.70% | 4.70% | 3.20% | 2.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -37.55% | -27.02% | 1.76% | -14.61% | 1.56% | 0.45% |
FCF Yield | 4.62% | 2.48% | 2.80% | 2.62% | 2.32% | 0.47% |
Dividend Yield | 1.14% | 0.80% | 0.51% | 0.51% | 0.46% | 0.14% |
Payout Ratio | - | - | 26.32% | - | 27.66% | 25.51% |
Buyback Yield / Dilution | 0.08% | 0.07% | -0.09% | - | -18.12% | -5.60% |
Total Shareholder Return | 1.20% | 0.87% | 0.42% | 0.51% | -17.66% | -5.45% |